Compare IOT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOT | SNN |
|---|---|---|
| Founded | 2015 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 14.3B |
| IPO Year | 2021 | N/A |
| Metric | IOT | SNN |
|---|---|---|
| Price | $31.68 | $32.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $45.42 | $36.25 |
| AVG Volume (30 Days) | ★ 8.3M | 841.3K |
| Earning Date | 06-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.28% |
| EPS Growth | ★ 48.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,249,199,000.00 | N/A |
| Revenue This Year | $19.67 | $7.19 |
| Revenue Next Year | $19.62 | $5.36 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | ★ 33.26 | N/A |
| 52 Week Low | $23.38 | $23.91 |
| 52 Week High | $48.41 | $38.79 |
| Indicator | IOT | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 56.05 | 37.60 |
| Support Level | $23.76 | $32.08 |
| Resistance Level | $36.04 | $33.89 |
| Average True Range (ATR) | 1.59 | 0.71 |
| MACD | 0.57 | -0.44 |
| Stochastic Oscillator | 66.68 | 11.80 |
Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows.. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers ranges from small and medium-sized businesses to state and local governments.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.